CATX

Perspective Therapeutics, Inc.

$4.18-0.09 (-2.11%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Perspective Therapeutics, Inc. (CATX) is a publicly traded company with 8 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 8 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.

Latest Insider Transactions

Showing 10 of 12 transactions (past 365 days)

CATX
Director
Award
$267.5K
Martinez Maria E50,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
Director
Award
$267.5K
Morich Frank50,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
Director
Award
$267.5K
Williamson Robert F Iii50,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
Director
Award
$267.5K
Henson Heidi50,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
Director
Award
$267.5K
Woods Lori A50,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
CEO
Award
$3.9M
Spoor Johan M.735,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
CAO
Award
$481.5K
Hunt Jonathan Robert90,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
CMO
Award
$802.5K
Puhlmann Markus150,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
CAO
Purchase
$22.3K
Hunt Jonathan Robert11,000 shares @ $2.03
Filed 2025-11-17Trade 2025-11-13
CATX
Director
Purchase
$19.9K
Williamson Robert F Iii9,498 shares @ $2.10
Filed 2025-11-14Trade 2025-11-12

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →